Yu, Siwei
Han, Ruyue
Gan, Runliang
Funding for this research was provided by:
National Natural Science Foundation of China (No. 81372134, No. 81372134)
Natural Science Foundation of Hunan Province (No. 2021JJ30590, No. 2021JJ30590)
Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study (2014-405, 2014-405)
Scientific Research Fund Project of Hunan Provincial Health Commission (No.20201921, No.20201921)
Article History
Received: 13 July 2022
Revised: 12 September 2022
Accepted: 12 September 2022
First Online: 13 October 2022
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare no conflicts of interest.